Lansoprazole Teva-Ratiopharm

Lansoprazole, the active ingredient in Lansoprazole Teva‑Ratiopharm, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat acid‑related disorders such as gastro‑esophageal reflux disease, peptic ulcer disease and Helicobacter pylori infection in adult patients.

GNH USA supplies Lansoprazole Teva‑Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Lansoprazole is a proton pump inhibitor indicated for several acid‑related gastrointestinal conditions. - Gastroesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by reducing acid exposure. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence by suppressing gastric acid. - Helicobacter pylori eradication therapy: enhances the effectiveness of antibiotic regimens used to eliminate H. pylori infection.

Lansoprazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild, transient pain often reported. - Diarrhea: loose stools occurring during treatment. - Abdominal pain: discomfort or cramps in the stomach area. - Nausea: feeling of sickness or urge to vomit. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Severe allergic reactions: rash, swelling, or anaphylaxis requiring emergency care. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: rare skin blistering disorders. - Liver enzyme elevation: signs of hepatic injury detected in lab tests. - Low serum magnesium: may cause muscle cramps or cardiac arrhythmias. - Increased risk of bone fractures: especially with long‑term use.

Before prescribing Lansoprazole, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: dose adjustment may be needed in severe impairment. - Use caution in elderly patients: higher risk of fractures and infections. - Monitor for gastrointestinal infections: prolonged acid suppression can predispose to C. difficile. - Avoid long‑term therapy unless clearly indicated: limit duration to reduce adverse outcomes. - Review concomitant medications: potential interactions may require dose modifications. - Store at room temperature: keep in the original container, protect from moisture and heat.

Lansoprazole can affect the absorption or metabolism of several drugs, necessitating careful management.

Major Interactions (Avoid): - Ketoconazole and other azole antifungals: reduced absorption leading to therapeutic failure. - Atazanavir and other protease inhibitors: decreased plasma levels compromising antiviral efficacy. - Clopidogrel: diminished activation, potentially reducing antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: increased anticoagulant effect may require INR monitoring. - Digoxin: higher serum concentrations may occur, necessitating level checks. - Methotrexate: reduced clearance can raise toxicity risk, especially at high doses.